Sign in

CIK 0001858848

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813789973
Phone
+1 415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-08-16 Tingley Whittemore Chief Medical Officer Sale −1,625 $2.89 $5K 107,106
2024-08-16 Ali Faraz Chief Executive Officer Sale −5,802 $2.89 $17K 192,277
2024-08-16 Ali Faraz Chief Executive Officer Sale −3,946 $2.89 $11K 188,331
2024-08-15 Saito Chihiro SVP, Accounting and Fin. Ops. Grant or award +25,000 65,604
2024-03-05 Hoey Timothy Chief Scientific Officer Sale 10b5-1 −3,300 $7.00 $23K 245,346
2024-02-23 Hoey Timothy Chief Scientific Officer Grant or award +12,500 248,646
2024-02-23 Hoey Timothy Chief Scientific Officer Grant or award · Stock Option (Right to buy) +75,000 75,000
2024-02-23 Tingley Whittemore Chief Medical Officer Grant or award +35,000 108,534
2024-02-23 Tingley Whittemore Chief Medical Officer Grant or award · Stock Option (Right to buy) +215,000 215,000
2024-02-23 PATTERSON LEONE D Chief Fin. and Bus. Officer Grant or award +35,000 95,755
2024-02-23 PATTERSON LEONE D Chief Fin. and Bus. Officer Grant or award · Stock Option (Right to buy) +205,000 205,000
2024-02-23 Ali Faraz Chief Executive Officer Grant or award +85,000 198,079
2024-02-23 Ali Faraz Chief Executive Officer Grant or award · Stock Option (Right to buy) +505,000 505,000
2024-02-20 Hoey Timothy Chief Scientific Officer Sale 10b5-1 −6,369 $5.31 $34K 236,346
2024-02-20 Hoey Timothy Chief Scientific Officer Sale 10b5-1 −200 $6.17 $1K 236,146
2024-02-16 Hoey Timothy Chief Scientific Officer Sale −4,681 $5.86 $27K 242,715
2024-02-16 Tingley Whittemore Chief Medical Officer Sale −6,500 $5.86 $38K 73,534
2024-02-16 PATTERSON LEONE D Chief Fin. and Bus. Officer Sale −5,201 $5.86 $30K 60,755
2024-02-16 Ali Faraz Chief Executive Officer Sale −6,358 $5.86 $37K 113,079
2024-02-12 COLUMN GROUP III GP, LP 10% owner Purchase +2,222,222 $4.50 $10.0M 13,599,275

Page 7 of 12 · 228 trades